NYSE:GKOS (USA) Also trade in: Germany

Glaukos Corp

$ 77.6 0.26 (0.33%)
Volume: 99,551 Avg Vol (1m): 390,608
Market Cap $: 2.82 Bil Enterprise Value $: 2.67 Bil
P/E (TTM): 0.00 P/B: 15.11
Earnings Power Value 5.83
Net Current Asset Value 3.9
Tangible Book 5.12
Projected FCF 0
Median P/S Value 51.37
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt ranked higher than
82.44% of 205 companies
in the Medical Instruments & Supplies industry.
Industry Max: 10000, Med: 1.74, Min: 0.01
GKOS: No Debt
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.12, Med: 10000, Max: 10000
Current: 10000
0.12
10000
Equity-to-Asset 0.81
Equity-to-Asset ranked higher than
82.14% of 196 companies
in the Medical Instruments & Supplies industry.
Industry Max: 2.26, Med: 0.6, Min: -5.6
GKOS: 0.81
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -5.81, Med: 0.85, Max: 0.89
Current: 0.81
-5.81
0.89
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 34.77
DISTRESS
GREY
SAFE
Beneish M-Score -1.58
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -38.1%
WACC 12.9%

Profitability & Growth : 5/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -5.75
Operating Margin ranked lower than
60.70% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 239.27, Med: 4.41, Min: -219137.5
GKOS: -5.75
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -67.78, Med: -10.77, Max: 3.71
Current: -5.75
-67.78
3.71
Net Margin % -5.93
Net Margin ranked lower than
60.70% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 182.67, Med: 4.18, Min: -221450
GKOS: -5.93
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -60.34, Med: -16.87, Max: 3.95
Current: -5.93
-60.34
3.95
ROE % -7.11
ROE ranked lower than
60.61% of 198 companies
in the Medical Instruments & Supplies industry.
Industry Max: 95.67, Med: 5.43, Min: -1452.51
GKOS: -7.11
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -8.3, Med: -0.07, Max: 4.26
Current: -7.11
-8.3
4.26
ROA % -6.03
ROA ranked lower than
58.25% of 206 companies
in the Medical Instruments & Supplies industry.
Industry Max: 46.82, Med: 1.85, Min: -307.58
GKOS: -6.03
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -52.2, Med: -23.94, Max: 3.6
Current: -6.03
-52.2
3.6
ROC (Joel Greenblatt) % -41.76
ROC (Joel Greenblatt) ranked lower than
67.16% of 204 companies
in the Medical Instruments & Supplies industry.
Industry Max: 387.24, Med: 9.63, Min: -114200
GKOS: -41.76
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -1308.7, Med: -377.19, Max: 45.47
Current: -41.76
-1308.7
45.47
3-Year Total Revenue Growth Rate 36.20
3-Year Revenue Growth Rate ranked higher than
94.12% of 170 companies
in the Medical Instruments & Supplies industry.
Industry Max: 1424.9, Med: 4.1, Min: -100
GKOS: 7.8
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 7.8, Med: 36.2, Max: 55
Current: 7.8
7.8
55
3-Year Total EBITDA Growth Rate 41.10
3-Year EBITDA Growth Rate ranked lower than
100.00% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 426.6, Med: 10, Min: -759
GKOS: 53.4
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 53.4
Current: 53.4
0
53.4
3-Year EPS w/o NRI Growth Rate 44.20
3-Year EPS w/o NRI Growth Rate ranked higher than
97.42% of 155 companies
in the Medical Instruments & Supplies industry.
Industry Max: 253, Med: 12.9, Min: -782.7
GKOS: 44.2
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 44.2, Max: 81.9
Current: 44.2
0
81.9

» GKOS's 30-Y Financials

Financials (Next Earnings Date: 2019-08-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:GKOS

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 339112    SIC : 3841
Compare NAS:OSUR SZSE:300677 LSE:AMS SZSE:300595 NAS:ATRI XMCE:FAE NAS:LMNX TSE:7730 TSE:7780 TSE:3593 SZSE:300358 SZSE:300171 XKLS:7153 SZSE:300061 NAS:ATRC NAS:LMAT SHSE:603222 SZSE:002414 XKRX:145720 XKRX:048260
Traded in other countries 6GJ.Germany
Address 229 Avenida Fabricante, San Clemente, CA, USA, 92672
Glaukos Corp is an ophthalmic medical technology company that develops and commercializes products and procedures used to treat glaucoma. The firm receives virtually all of its revenue from sales of its iStent products, which are primarily sold to hospitals and surgery centers. The iStent is a micro-invasive glaucoma surgery device that reduces intraocular pressure by restoring the natural outflow pathways for aqueous humor, the thin fluid that circulates the eye. It can lower pressure in adult patients with mild to moderate open-angle glaucoma. Glaukos generates the vast majority of its revenue in the United States.

Ratios

Current vs industry vs history
PB Ratio 15.11
PB Ratio ranked lower than
84.46% of 193 companies
in the Medical Instruments & Supplies industry.
Industry Max: 53.91, Med: 3.45, Min: 0.13
GKOS: 15.11
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 5.19, Med: 9.88, Max: 16.17
Current: 15.11
5.19
16.17
PS Ratio 14.18
PS Ratio ranked lower than
77.08% of 192 companies
in the Medical Instruments & Supplies industry.
Industry Max: 720.69, Med: 3.48, Min: 0.08
GKOS: 14.18
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 1.97, Med: 9.41, Max: 15
Current: 14.18
1.97
15
Price-to-Free-Cash-Flow 174.79
Price-to-Free-Cash-Flow ranked lower than
82.43% of 74 companies
in the Medical Instruments & Supplies industry.
Industry Max: 794.44, Med: 28.61, Min: 0.95
GKOS: 174.79
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 46.05, Med: 201.19, Max: 635.64
Current: 174.79
46.05
635.64
Price-to-Operating-Cash-Flow 108.61
Price-to-Operating-Cash-Flow ranked lower than
82.98% of 94 companies
in the Medical Instruments & Supplies industry.
Industry Max: 807.55, Med: 21.15, Min: 0.86
GKOS: 108.61
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 34.95, Med: 105.7, Max: 329.81
Current: 108.61
34.95
329.81
EV-to-EBIT -238.10
EV-to-EBIT ranked lower than
100.00% of 121 companies
in the Medical Instruments & Supplies industry.
Industry Max: 126.36, Med: 23.93, Min: 0.21
GKOS: -238.1
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -2890.1, Med: -144.9, Max: 482.6
Current: -238.1
-2890.1
482.6
EV-to-EBITDA -496.64
EV-to-EBITDA ranked lower than
97.83% of 138 companies
in the Medical Instruments & Supplies industry.
Industry Max: 614.98, Med: 19.49, Min: 0.2
GKOS: -496.64
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -8497.5, Med: -13.5, Max: 573.9
Current: -496.64
-8497.5
573.9
EV-to-Revenue 13.78
EV-to-Revenue ranked lower than
70.35% of 199 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4881, Med: 3.57, Min: 0.12
GKOS: 13.78
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.1, Med: 9.8, Max: 14.5
Current: 13.78
0.1
14.5
Current Ratio 6.72
Current Ratio ranked higher than
80.50% of 200 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.7, Med: 2.57, Min: 0.1
GKOS: 6.72
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.52, Med: 6.01, Max: 8.45
Current: 6.72
0.52
8.45
Quick Ratio 6.23
Quick Ratio ranked higher than
85.07% of 201 companies
in the Medical Instruments & Supplies industry.
Industry Max: 30.69, Med: 1.87, Min: -1.52
GKOS: 6.23
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.41, Med: 5.72, Max: 7.94
Current: 6.23
0.41
7.94
Days Inventory 184.84
Days Inventory ranked lower than
57.36% of 197 companies
in the Medical Instruments & Supplies industry.
Industry Max: 876.25, Med: 124.35, Min: 0.86
GKOS: 184.84
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 65.71, Med: 140.03, Max: 266.8
Current: 184.84
65.71
266.8
Days Sales Outstanding 38.57
Days Sales Outstanding ranked higher than
84.24% of 165 companies
in the Medical Instruments & Supplies industry.
Industry Max: 655.77, Med: 61.97, Min: 1
GKOS: 38.57
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 37.6, Med: 40.83, Max: 50.4
Current: 38.57
37.6
50.4
Days Payable 78.46
Days Payable ranked higher than
80.13% of 151 companies
in the Medical Instruments & Supplies industry.
Industry Max: 713.41, Med: 54.66, Min: 2
GKOS: 78.46
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 66.94, Med: 103.67, Max: 480.19
Current: 78.46
66.94
480.19

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.10
3-Year Share Buyback Rate ranked lower than
73.43% of 143 companies
in the Medical Instruments & Supplies industry.
Industry Max: 9.1, Med: -5, Min: -273.3
GKOS: -3.1
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -11.6, Med: -10.9, Max: -3.1
Current: -3.1
-11.6
-3.1

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 15.13
Price-to-Tangible-Book ranked lower than
71.86% of 167 companies
in the Medical Instruments & Supplies industry.
Industry Max: 3100, Med: 4.77, Min: 0.22
GKOS: 15.13
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 6.14, Med: 10.14, Max: 15.3
Current: 15.13
6.14
15.3
Price-to-Median-PS-Value 1.51
Price-to-Median-PS-Value ranked higher than
67.50% of 160 companies
in the Medical Instruments & Supplies industry.
Industry Max: 4.9, Med: 1.13, Min: 0.01
GKOS: 1.51
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.23, Med: 1.04, Max: 1.59
Current: 1.51
0.23
1.59
Earnings Yield (Joel Greenblatt) % -0.42
Earnings Yield (Greenblatt) ranked lower than
60.87% of 207 companies
in the Medical Instruments & Supplies industry.
Industry Max: 476.19, Med: 2.4, Min: -3333.33
GKOS: -0.42
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -8390.6, Med: -0.5, Max: 2841.8
Current: -0.42
-8390.6
2841.8

More Statistics

Revenue (TTM) (Mil) $ 195.17
EPS (TTM) $ -0.34
Beta 1.78
Volatility % 73.42
52-Week Range $ 36.89 - 83.14
Shares Outstanding (Mil) 36.4

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y